A Prospective Observational Comparative Study on Drug Related Problems among Respiratory Disorder Patients and Evaluating the Role of Pharmacist in Challenging the DRP’s

DOI

10.2991/978-94-6463-813-4_23How to use a DOI?

Keywords

Pharmaceutical care network (PCNE); Adverse drug reaction (ADR); Medication error (ME); drug related problems (DRP); Chronic Obstructive pulmonary disease (COPD)

Abstract

Although advanced technology and computerized systems have improved the field of medicine, we still see medication errors. Globally, respiratory disorders and their associated drug related problems have a significant impact, A study found that medication non adherence in asthma patients resulted in additional $1400 per patient per year in health care cost, hospitalizations due to COPD exacerbations cost an estimated $13.2 billion annually in the US. Reducing mortality from non-communicable disease including respiratory disorders by 25%by 2030. Approximately 20–30% of respiratory patients suffer significant medication related issues, leading to avoidable exacerbations, hospitalizations and deaths, underscoring the need for robust interventions to identify and manage DRPs effectively. The classification for drug-related issues V9.1 was utilized to evaluate and categorize the findings of this research. This research offers a standardized framework for categorizing the interventions. This article we have investigated efficacy of Treatment, pharmaceutical problems within the pulmonology department of two tertiary hospitals. Hospital - 2 exhibits a higher prevalence of drug related problems compared to hospital-1. Student T-test is used and different p variables are obtained. As we are aware of treatment of respiratory disorder which include polypharmacy and multiple drug therapy are prevalent among respiratory disorder patients leading to a significant increase in drug related problems, affecting [insert percentage or number]of patients. these also resulted in economic burden and adverse effects. By using different scales, we have assessed DRP’S among randomly selected patients and the factors leading to the above problems were characterized. Among all the factors, the following factors were identified to play an important role. The identified factors are Age, Gender, Social history, Comorbidities. The study emphasizes how important clinical pharmacist are to locating, analyzing, and resolving DRPs in order to maximize pharmaceutical therapy and enhance patient outcomes.

Copyright

© 2025 The Author(s)

Open Access

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

TY  - CONF
AU  - Kakarla Kalyani Reddy
AU  - Jetti Anusha
AU  - Surisetti Rajesh
AU  - Gudise Pravalika
AU  - Thanati Joel Nathan
AU  - Mallela Maharshi
PY  - 2025
DA  - 2025/08/13
TI  - A Prospective Observational Comparative Study on Drug Related Problems among Respiratory Disorder Patients and Evaluating the Role of Pharmacist in Challenging the DRP’s
BT  - Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)
PB  - Atlantis Press
SP  - 304
EP  - 316
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-813-4_23
DO  - 10.2991/978-94-6463-813-4_23
ID  - Reddy2025
ER  -